Placebo News and Research

RSS

New TB vaccine: mid-phase trials confirm safety, long-term prevention

A new study published on October 29, 2019, in the New England Journal of Medicine, reports a new vaccine which could change the face of tuberculosis prevention. The disease kills 1.5 million people worldwide each year.

30 Oct 2019

IU researcher receives NIH grant to perform clinical trial on cirrhosis

An Indiana University School of Medicine researcher has been awarded a five-year, $1.8 million grant from the National Institutes of Health for a clinical trial, aimed at providing new avenues to improve liver function for patients with alcoholic cirrhosis.

30 Oct 2019

Homeopathy quackery - NHS leaders urge caution

A new controversy is ripe, what with the head of the UK National Health Service (NHS), Simon Stevens, publicly expressing his “serious concerns” about the “fundamentally flawed” practice of homeopathy.

29 Oct 2019

Anti-inflammatory agents can safely, effectively reduce symptoms of major depression

Anti-inflammatory agents, such as aspirin/paracetamol, statins, and antibiotics, can safely and effectively curb the symptoms of major depression, finds a pooled analysis of the available evidence, published online in the Journal of Neurology Neurosurgery & Psychiatry.

29 Oct 2019

Mindfulness meditation can boost positive long-term effects of psilocybin

Recent years have seen a renewed interest in the clinical application of classic psychedelics in the treatment of depression and anxiety disorders.

24 Oct 2019

NIA-funded study to examine overall benefits and risks of statins in older adults

The National Institute on Aging has funded a major study to examine the overall benefits and risks of cholesterol-lowering drugs known as statins in adults age 75 or older without cardiovascular disease.

23 Oct 2019

UAB researchers awarded grant to study a vaccine for gonorrhea

University of Alabama at Birmingham researchers have been awarded a three-year contract with a total potential amount of $10 million to study the efficacy of the vaccine Bexsero - already licensed to prevent meningitis - in protecting vulnerable populations from infection with the bacteria that causes gonorrhea.

23 Oct 2019

Therapy for common vision disorder fails to improve children's reading test scores

Results from a clinical trial funded by the National Eye Institute (NEI) show that while vision therapy can successfully treat convergence insufficiency (CI) in children, it fails to improve their reading test scores.

23 Oct 2019

Study finds little evidence on effectiveness of common antidepressant in autism spectrum disorders

A new study has found there is little evidence that a widely used antidepressant is effective at reducing obsessive compulsive behaviours in children and adolescents with autism spectrum disorders.

23 Oct 2019

Study dispels the hypothesis that metformin could help exercising seniors gain more muscle mass

A clinical trial initiated by University of Kentucky researchers argues against the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass. The double-blind trial, conducted at the University of Kentucky and University of Alabama at Birmingham, found that older adults who took metformin while performing rigorous resistance exercise training had smaller gains in muscle mass than the placebo group.

22 Oct 2019

Study blunts hopes that diabetes drug could help exercising seniors gain more muscle mass

A new clinical trial dispels the hypothesis that the diabetes drug metformin could help exercising seniors gain more muscle mass.

22 Oct 2019

New findings demonstrate how subtle social interactions can impact clinical outcomes

If a doctor expects a treatment to be successful, a patient may experience less pain and have better outcomes, according to a new Dartmouth study published in Nature Human Behaviour.

21 Oct 2019

Systematic review: Medical marijuana shows early promise to lessen opioid use

Medical marijuana shows early promise to lessen opioid use and potential abuse, suggests a systematic review of published studies being presented at the ANESTHESIOLOGY 2019 annual meeting.

20 Oct 2019

Widely available drug could reduce deaths in traumatic brain injury patients, major study shows

A low cost and widely available drug could reduce deaths in traumatic brain injury patients by as much as 20%, depending on the severity of injury, according to a major study published in The Lancet.

15 Oct 2019

Novel clinical trial to examine use of cannabidiol in people with Parkinson's-related psychosis

A pioneering clinical trial will investigate the use of cannabidiol (CBD) - a compound found in the cannabis plant - in people with Parkinson's-related psychosis.

14 Oct 2019

Pittcon 2020 Plenary Lecture announced

Pittcon is pleased to announce Dr. Ziva Cooper as the 2020 Plenary Lecturer. Dr. Cooper’s lecture is entitled Cannabis Constituents as Novel Strategies to Tackle the Opioid Epidemic.

From Pittcon 11 Oct 2019

UC San Diego's CMCR announces research grants to explore cannabis for medical applications

The Center for Medicinal Cannabis Research (CMCR) at University of California San Diego School of Medicine, the nation's oldest research center for scientific inquiry into the safety and efficacy of cannabis, has announced $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.

11 Oct 2019

‘Sticky’ gene may boost the nerve calming effects of Valium

Between 1999 and 2017, the United States experienced a 10-fold increase in the number of people who died from overdoses of Valium and other benzodiazepines.

10 Oct 2019

Suppressing brain immune cells might prevent or delay the onset of dementia

Messy tangles of a protein called tau can be found in the brains of people with Alzheimer's disease and some other neurodegenerative diseases. In Alzheimer's, the tangles coalesce just before tissue damage becomes visible in brain scans and people start to become forgetful and confused.

10 Oct 2019

Melatonin may not help prevent delirium following major cardiac surgery

Delirium is observed in approximately 15% of hospitalized older adults, and it is more common in the critically ill and in those undergoing major surgery, such as heart surgery.

9 Oct 2019

Placebo News and Research

New TB vaccine: mid-phase trials confirm safety, long-term prevention

IU researcher receives NIH grant to perform clinical trial on cirrhosis

Homeopathy quackery - NHS leaders urge caution

Anti-inflammatory agents can safely, effectively reduce symptoms of major depression

Mindfulness meditation can boost positive long-term effects of psilocybin

NIA-funded study to examine overall benefits and risks of statins in older adults

UAB researchers awarded grant to study a vaccine for gonorrhea

Therapy for common vision disorder fails to improve children's reading test scores

Study finds little evidence on effectiveness of common antidepressant in autism spectrum disorders

Study dispels the hypothesis that metformin could help exercising seniors gain more muscle mass

Study blunts hopes that diabetes drug could help exercising seniors gain more muscle mass

New findings demonstrate how subtle social interactions can impact clinical outcomes

Systematic review: Medical marijuana shows early promise to lessen opioid use

Widely available drug could reduce deaths in traumatic brain injury patients, major study shows

Novel clinical trial to examine use of cannabidiol in people with Parkinson's-related psychosis

Pittcon 2020 Plenary Lecture announced

UC San Diego's CMCR announces research grants to explore cannabis for medical applications

‘Sticky’ gene may boost the nerve calming effects of Valium

Suppressing brain immune cells might prevent or delay the onset of dementia

Melatonin may not help prevent delirium following major cardiac surgery

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News